BSE filing, NSE: ROSSARI. Summary written from the filing by ALFA Finder's alert engine.
Rossari Biotech Ltd: key numbers
- Share price
- ₹408.40
- Market cap
- ₹2,262 Cr
- Revenue (annual)
- ₹2,396 Cr
- Net profit (annual)
- ₹149.2 Cr
- P/E (TTM)
- 14.8×Sector 34.1×
- Promoter holding
- 68.14%+0.00% QoQ
- FII holding
- 1.84%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rossari Biotech Ltd
All →Rossari Biotech Earnings Call Transcript: Key Takeaways
Rossari Biotech achieved record quarterly revenue and EBITDA despite volatile raw material costs and logistical headwinds.
- Call
- Guides 15% growth
Rossari Biotech Results Update
Rossari Biotech reported Q2 FY27 revenue of Rs. 697.6 crore, up 19% YoY. The company also announced plans for a new manufacturing facility in Saudi Arabia.
Rossari Biotech Investor Presentation: Key Takeaways
Rossari Biotech reported record quarterly revenue of Rs. 697.6 Cr (up 19% YoY) and EBITDA of Rs. 87 Cr (up 21% YoY). Performance driven by volume and product mix.
Rossari Biotech Q2 FY27 Results: Net Profit ₹38.9 Cr, Up 5.4% YoY
Rossari Biotech Ltd reported revenue from operations of ₹697.6 Cr (+19.0% YoY) and net profit of ₹38.9 Cr (+5.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹38.9 Cr · +5.4% YoY
Rossari Biotech Other Announcement
Rossari Biotech submitted its quarterly shareholding pattern for the period ended September 30, 2026. The filing includes minor reporting adjustments for two promoter group members.
Rossari Biotech Board Meeting Date
Rossari Biotech will hold a board meeting on October 17, 2026, to consider and approve its unaudited financial results for the quarter ending September 30, 2026.
Other annual general meeting announcements
All →Tasty Bite Eatables Annual General Meeting
Tasty Bite Eatables declared postal ballot results approving a material related-party transaction with Mars Food UK Limited for purchase of a capital asset. Promoter group did not vote and the resolution passed with 99.99% of votes cast in favour.
Unihealth Hospitals Annual General Meeting
Unihealth Hospitals reported postal ballot results: all three resolutions passed, covering a related-party loan-to-equity conversion with UMC Hospitals, variation of unutilised IPO proceeds, and migration from NSE Emerge to the main board. No rupee amount is stated for the approvals.
Vedanta Iron and Steel Annual General Meeting
Vedanta Iron and Steel seeks shareholder approval via postal ballot for seven material related party transaction resolutions. E-voting runs from 29 October to 27 November 2026.
GTPL Hathway Annual General Meeting
GTPL Hathway seeks shareholder approval by postal ballot to appoint Gurjeev Singh Kapoor as Non-Executive Director. E-voting runs November 1 to 30, 2026.
HEG Advanced Materials Annual General Meeting
HEG Advanced Materials seeks approval via postal ballot to appoint seven directors and fix MD Riju Jhunjhunwala's remuneration. E-voting runs October 29 to November 27, 2026.
Trident Texofab Annual General Meeting
Trident Texofab's EGM on 28 October 2026 sought approval for a statutory auditor to fill a casual vacancy. Only one ordinary resolution was tabled.